|
Pancreatic Ductal Adenocarcinoma Pipeline Pancreatic Ductal Adenocarcinoma companies include Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix Biosystems, Eucure Biopharma, Panbela Therapeutics, Jeil Pharmaceutical, Elicio Therapeutics, Cend Therapeutics, SignalChem Lifesciences, Bristol Myers Squibb, AstraZeneca, REVOLUTION Medicines, Arcus Biosciences, ZielBio, Surface Oncology, … Continue reading
|
Osteoarthritis Pipeline Leading Osteoarthritis companies include Biosplice Therapeutics, Cynata Therapeutics, Regeneron Pharmaceuticals, LG Chem, Bioventus, Asahi Kasei Pharma, Ampio Pharmaceuticals, and several other innovators actively contributing to Osteoarthritis drug development. DelveInsight’s latest report, “Osteoarthritis Pipeline Insights 2026” offers a comprehensive … Continue reading
|
|
Ocular Hypertension Pipeline Ocular Hypertension companies include Santen Pharmaceutical, Nicox Ophthalmics, Allysta Pharmaceuticals, Qlaris Bio, Ripple Therapeutics, Laboratoires Théa, Ocular Therapeutix, Otsuka Beijing Research Institute, Alcon Research, AbbVie, Glaukos Corporation, MediPrint Ophthalmics, and Ocuphire Pharma, among others. DelveInsight’s latest report, … Continue reading
|
Artificial Intelligence in Diagnostics Market Artificial Intelligence in Diagnostics companies are Aidoc, Owkin, Siemens Healthineers, PathAI, Ibex, Imagen Technologies, Aiforia, RADLogics, Terarecon, Prenosis, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, and others. The global Artificial Intelligence (AI) in Diagnostics market … Continue reading
|
|
Nuclear Medicine (Radiopharmaceuticals) Market Insights Key companies operating in the nuclear medicine (radiopharmaceuticals) market include Lantheus, Cardinal Health, GE Healthcare, Curium Pharma, Pharmalogic Holdings Corp., Novartis, Cambridge Isotope Laboratories Inc., Sotera Health LLC, Bracco Imaging SpA, Jubilant Pharma Limited, NECSA … Continue reading
|
Hip Reconstruction/Replacement Devices Market Insights The global hip replacement devices market is poised for robust and sustained expansion, driven by the rising prevalence of bone-related disorders and continuous technological advancements by global players including, Exactech, Inc., Johnson & Johnson Services, … Continue reading
|
|
DelveInsight’s, “Metastatic Renal Cell Carcinoma Pipeline Insights 2026” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Metastatic Renal Cell Carcinoma pipeline landscape. It covers the Metastatic Renal Cell Carcinoma pipeline drug profiles, including clinical and nonclinical … Continue reading
|
DelveInsight’s “Epilepsy Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epilepsy pipeline … Continue reading
|
|
DelveInsight’s “Hereditary Angioedema Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 30+ pipeline drugs in Hthe ereditary Angioedema pipeline landscape. It covers the Hereditary Angioedema pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
|
DelveInsight’s, “Hypercholesterolemia Pipeline Insight, 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … Continue reading
|
